Generics

We manufacture our products by following our customers’ and health authorities’ most stringent requirements. DMF documentation for all our products is prepared in accordance with the latest requirements 
of EDQM (CEP), ICH (ASMF in eCTD format), and FDA (US DMF). Material and product testing is performed in line with the European and United States Pharmacopeias.

Search for product

abcdefghijklmnoprstuvxyz

Filters

Commercial

Pipeline

Therapeutic Category

Alimentary tract & metabolismAntifungal agentAnti-infectives for systemic useAntipyretic, analgesic and anti-inflammatoryAntineoplastic & immunomodulating agentsBlood & blood forming organsCardiovascular systemGenito-urinary system & sex hormonesInjectable FormsMusculo-skeletal systemNervous systemOpthalmological preparationsRespiratory systemOncology

Available EU DMF/CEP/US DMF

Injectable Forms

Reset filters

API product & pipeline (pdf)

Sort by

Alphabetical Therapeutic Category

Sort:

Alphabetical Therapeutic Category

Status

Therapeutic Category

Polymorphic form

CAS No.

    A

  • Acenocumarol

    StatusCommercial

    Therapeutic CategoryCardiovascular system

    Polymorphic form

    CAS No.152-72-7

    View more

  • Acetazolamide

    StatusCommercial

    Therapeutic CategoryCardiovascular system

    Polymorphic formForm II

    CAS No. 59-66-5

    View more

  • Alendronate sodium

    StatusCommercial

    Therapeutic CategoryMusculo-skeletal system

    Polymorphic formTrihydrate

    CAS No.121268-17-5

    View more

  • Aniracetam

    StatusCommercial

    Therapeutic CategoryNervous system

    Polymorphic formMonoclinic form

    CAS No.72432-10-1

    View more

  • Aripiprazole

    StatusCommercial

    Therapeutic CategoryNervous system

    Polymorphic formType I

    CAS No.129722-12-9

    View more

  • Aripiprazole monohydrate non-sterile

    StatusCommercial

    Therapeutic CategoryNervous system

    Polymorphic formMonohydrate

    CAS No.851220-85-4

    View more
    • B

  • Baclofen

    StatusCommercial

    Therapeutic CategoryMusculo-skeletal system

    Polymorphic formForm B

    CAS No.1134-47-0

    View more
    • C

  • Carbamazepine

    StatusCommercial

    Therapeutic CategoryNervous system

    Polymorphic formForm III

    CAS No.298-46-4

    View more

  • Carvedilol

    StatusCommercial

    Therapeutic CategoryCardiovascular system

    Polymorphic formForm II

    CAS No.72956-09-3

    View more

  • Carvedilol phosphate hemihydrate

    StatusCommercial

    Therapeutic CategoryCardiovascular system

    Polymorphic formForm I

    CAS No.610309-89-2

    View more

  • Clemastine fumarate

    StatusCommercial

    Therapeutic CategoryRespiratory system

    Polymorphic form

    CAS No.14976-57-9

    View more

  • Clopamide

    StatusCommercial

    Therapeutic CategoryCardiovascular system

    Polymorphic formPolymorphic form

    CAS No.636-54-4

    View more
    • D

  • Disulfiram

    StatusCommercial

    Therapeutic CategoryAlimentary tract & metabolism

    Polymorphic form

    CAS No.97-77-8

    View more
    • E

  • Etodolac

    StatusCommercial

    Therapeutic CategoryMusculo-skeletal system

    Polymorphic formCrystalline racemate, none

    CAS No.41340-25-4

    View more
    • H

  • Hydrochlorothiazide

    StatusCommercial

    Therapeutic CategoryCardiovascular system

    Polymorphic formForm I

    CAS No.58-93-5

    View more
    • I

  • Ibandronate sodium

    StatusCommercial

    Therapeutic CategoryMusculo-skeletal system

    Polymorphic formMonohydrate Form B

    CAS No.138926-19-9

    View more
    • L

  • Lamotrigine

    StatusCommercial

    Therapeutic CategoryNervous system

    Polymorphic formAnhydrous monoclinic

    CAS No.84057-84-1

    View more
    • M

  • Molsidomine

    StatusCommercial

    Therapeutic CategoryCardiovascular system

    Polymorphic form

    CAS No.25717-80-0

    View more
    • N

  • Nefopam hydrochloride

    StatusCommercial

    Therapeutic CategoryAntipyretic, analgesic and anti-inflammatory

    Polymorphic form

    CAS No.23327-57-3

    View more
    • O

  • Opipramol dihydrochloride

    StatusCommercial

    Therapeutic CategoryNervous system

    Polymorphic formAmorphous

    CAS No.909-39-7

    View more

  • Oxcarbazepine

    StatusCommercial

    Therapeutic CategoryNervous system

    Polymorphic formForm A

    CAS No.28721-07-5

    View more
    • P

  • Pentoxifylline

    StatusCommercial

    Therapeutic CategoryCardiovascular system

    Polymorphic formForm I

    CAS No.1677687

    View more

  • Phenyl salicylate

    StatusCommercial

    Therapeutic CategoryAntipyretic, analgesic and anti-inflammatory

    Polymorphic formCrystalline orthorhombic form

    CAS No.118-55-8

    View more

  • Piracetam

    StatusCommercial

    Therapeutic CategoryNervous system

    Polymorphic formForm II

    CAS No.7491-74-9

    View more
    • R

  • Risedronate sodium

    StatusCommercial

    Therapeutic CategoryMusculo-skeletal system

    Polymorphic formForm A

    CAS No.329003-65-8

    View more
    • S

  • Salicylamide

    StatusCommercial

    Therapeutic CategoryAntipyretic, analgesic and anti-inflammatory

    Polymorphic formMonoclinic form with space group 12/a

    CAS No.65-45-2

    View more

  • Sildenafil citrate

    StatusCommercial

    Therapeutic CategoryGenito-urinary system & sex hormones

    Polymorphic formAnhydrous Form 2

    CAS No.171599-83-0

    View more

  • Sitagliptin hydrochloride

    StatusCommercial

    Therapeutic CategoryAlimentary tract & metabolism

    Polymorphic formPolymorphic form III

    CAS No.862156-92-1

    View more

  • Sodium salicylate

    StatusCommercial

    Therapeutic CategoryAlimentary tract & metabolism

    Polymorphic formMonoclinic form (space group P21/m)

    CAS No.54-21-7

    View more
    • T

  • Tadalafil

    StatusCommercial

    Therapeutic CategoryGenito-urinary system & sex hormones

    Polymorphic formForm A (form I)

    CAS No.171596-29-5

    View more

  • Tolterodine tartrate

    StatusCommercial

    Therapeutic CategoryGenito-urinary system & sex hormones

    Polymorphic formCrystalline Form I

    CAS No. 124937-52-6

    View more

  • Topiramate

    StatusCommercial

    Therapeutic CategoryNervous system

    Polymorphic formOrthorhombic structure

    CAS No.97240-79-4

    View more
    • V

  • Vardenafil hydrochloride

    StatusCommercial

    Therapeutic CategoryGenito-urinary system & sex hormones

    Polymorphic formTrihydrate form

    CAS No.330808-88-3

    View more
    • X

  • Xylometazoline hydrochloride

    StatusCommercial

    Therapeutic CategoryRespiratory system

    Polymorphic form

    CAS No.1218-35-5

    View more
    • Z

  • Zoledronic acid

    StatusCommercial

    Therapeutic CategoryMusculo-skeletal system

    Polymorphic formMonohydrate

    CAS No.165800-06-6

    View more